XML 18 R6.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net loss $ (24,391,594) $ (9,794,073)
Adjustments to reconcile net loss to net cash used in operating activities:    
Loss on disposal of fixed assets 150,673  
Depreciation and amortization 405,450 331,406
Stock-based compensation 5,481,938 3,265,412
Restricted stock awards granted 257,461  
Changes in lease liabilities (16,844) (10,100)
Changes in operating assets and liabilities:    
Receivables 10,308,655 10,002,993
Prepaid expenses and other assets 87,147 (130,068)
Other assets (31,674) (25,550)
Accounts payable and accrued expenses 1,315,268 (1,584)
Deferred revenue   (4,906,876)
Net cash used in operating activities (6,433,520) (1,268,440)
Cash flows from investing activities:    
Purchase of marketable securities (18,181,600) (33,210,697)
Proceeds from sales and maturities of marketable securities 43,212,559 24,373,000
Purchases of property and equipment (896,007) (608,588)
Payments for leasehold improvements (244,279) (55,729)
Net cash provided by (used in) investing activities 23,890,673 (9,502,014)
Cash flows from financing activities:    
Net proceeds from sale of common stock   2,290,244
Proceeds from exercise of stock awards and warrants 50,354  
Net cash provided by financing activities 50,354 2,290,244
Net increase (decrease) in cash and cash equivalents 17,507,507 (8,480,210)
Cash and cash equivalents balance at beginning of period 11,286,996 14,694,857
Cash and cash equivalents balance at end of period $ 28,794,503 $ 6,214,647